Position in MRK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$13,114,710
+$416,778 QoQ
Shares Held
102,060
-3.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#649
of 3,768 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prospera Financial Services Inc holds $193,149,306 across 14 Drug Manufacturers - General names. MRK ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,944 | $56,306,046 | |
| 2 | JNJ |
Johnson & Johnson
|
174,910 | $44,421,892 | |
| 3 | ABBV |
AbbVie Inc.
|
96,118 | $24,187,133 | |
| 4 | NVO |
Novo Nordisk A S
|
308,903 | $14,808,809 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
102,060 | $13,114,710 | |
| 6 | AZN |
Astrazeneca PLC
|
56,268 | $10,669,538 | |
| 7 | AMGN |
Amgen Inc
|
26,804 | $9,706,264 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
71,841 | $9,076,391 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,114,710 | 102,060 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $12,697,932 | 105,561 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $12,369,839 | 117,517 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $9,276,447 | 110,526 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $8,108,358 | 102,430 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $13,686,604 | 152,480 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,091,766 | 131,602 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $21,919,124 | 193,018 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $22,733,517 | 183,631 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $18,712,489 | 141,815 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $13,186,841 | 120,958 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,489,117 | 111,599 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,718,577 | 92,890 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $10,678,151 | 100,368 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,600,052 | 95,539 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $11,938,212 | 138,623 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $11,352,579 | 124,521 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $7,306,060 | 89,044 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $4,782,795 | 62,406 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,419,096 | 58,835 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $3,883,410 | 50,375 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $4,106,685 | 50,204 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,740,337 | 33,036 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $3,565,069 | 46,102 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,431,237 | 18,602 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||